However, the tumor microenvironment can limit the conversion of oxidative phosphorylation to aerobic glycolysis by maintaining high expression of microRNA101 and microRNA26a, and limit the expression of EZH2 in T cells by controlling glucose metabolism. The gene discussed is EZH2; the disease is neoplasm.